Circulating complement (C3 and C4) for differentiation of SIRS from sepsis

Area of Science:

• Critical Care Medicine
• Infectious Diseases
• Laboratory Hematology

Background:

• Sepsis, a life-threatening response to infection, involves significant inflammatory activation.
• The complement system (C3 and C4) and C-reactive protein (CRP) are known inflammatory markers.
• Differentiating sepsis from Systemic Inflammatory Response Syndrome (SIRS) is crucial for timely and appropriate treatment.

Purpose of the Study:

• To compare the efficacy of serum C3 and C4 levels, CRP, and thrombocyte/leukocyte counts in differentiating SIRS from sepsis.
• To identify the most reliable laboratory parameter for distinguishing between SIRS and sepsis in intensive care unit (ICU) patients.

Main Methods:

• Prospective study over 6 months involving ICU patients diagnosed with SIRS or sepsis.
• Clinical status recorded at admission, followed by blood sampling for complete blood count, CRP, C3, and C4.
• Statistical analysis to compare laboratory parameters between SIRS and sepsis groups.

Main Results:

• A significantly lower mean thrombocyte count was observed in septic patients (179,975±95,615) compared to SIRS patients (243,165±123,706) (P=.005).
• No significant differences were found in plasma concentrations of CRP or levels of C3 and C4 between the two groups.
• Thrombocyte count demonstrated the highest area under the curve (0.656), indicating it as the most reliable differentiator.

Conclusions:

• Thrombocyte count is a more reliable marker than CRP, C3, or C4 levels for differentiating sepsis from SIRS in ICU settings.
• Lower thrombocyte counts may serve as an early warning sign for sepsis in critically ill patients.
• Further research could explore the combined utility of thrombocyte counts with other clinical parameters for improved sepsis diagnosis.